The expression of serum anti-CXCL8 autoantibody in clinical subgroups divided by gender, age, tumor site, family tumor history, differentiation, TNM stage, lymphatic metastasis, and distance metastasis was further studied. The gene discussed is CXCL8; the disease is neoplasm.